Cecilia G Freeman, Ryan Durgham, Emily Ren, Keith R Conti, Heather Yeakel, Timothy Fan, David M Brown, Jason F Ohlstein, Jarrod A Keeler
Objectives: Obstructive sleep apnea (OSA) is a prevalent sleep disorder that can increase the risk of hypertension, diabetes, obesity, and cardiovascular diseases. Hypoglossal nerve stimulation (HGNS) is an alternative therapy for OSA in patients who cannot tolerate continuous positive airway pressure. Understanding the impact of HGNS on blood pressure, hemoglobin A1C (A1C), and body mass index (BMI) currently remains limited. Methods: A retrospective review study of HGNS outcomes at a single practice from January 2020 to November 2022 was conducted...
February 29, 2024: Ear, Nose, & Throat Journal